The growing prevalence of chronic kidney disorder among the population and other major driving factors is expected to favor the rise in the cystatin C testing market
Reports and Insights has published a new report titled, “Cystatin C Testing Market: Opportunity Analysis and Future Assessment 2022-2030”
Global Cystatin C Testing Market, By Component Type (Cartridges, Detection, Buffer tubes, ID chip), By Sample Type (Serum, Plasma, Heparin, EDTA), By Type (Colorimetric Assay Based Tests, Enzymatic Tests, ELISA Based Tests, Others), By End-User (Hospitals, Clinics, Diagnostic Centres), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2022 and 2030.The Cystatin C testing market is expected to grow at a significant growth rate in the upcoming years.
Cystatin C testing is paving the way by using new approaches to diagnose and treat people. Cystatin have been extensively used for analysis of renal functions and glomerular filtration rate (GFR) that is the measurement of serum creatinine and creatinine clearance rate for keeping a check on the functioning of kidneys. This has been extremely useful in clinical medicine regardless of the complexities related to its quantification and interpretation. Attributing to its sensitivity and specificity for kidney function as both innate and transplanted kidneys, the cystatin C is considered to have an enormous potential as a promising marker at it incorporates the capability to carry out a quick and accurate analysis of renal functions which is majorly expected to drive the cystatin C testing market in the forthcoming future.
In addition to that, Cystatin C testing market is expected to grow at a rapid pace in the near future owing to the rising prevalence of various disorders among the population such as myocardial infarction, muscular dystrophy and kidney related disorders. For instance, according to National Kidney Organization, in U.S. approximately 80 Mn individuals are at a risk of kidney disorder out of which its more common in women (14%) than in men (12%). Thus, kidney disease is one the major factor which is projected to foster the growth of the global cystatin C testing market over the years. Moreover, the increasing number of hospitals, research laboratories, diagnostic centers and academic labs is propelling the growth of the global cystatin C testing market globally. Furthermore, the cost effectiveness of the reagents and awareness of health-related disorders is estimated to boost the growth of the global cystatin C testing market over the forecast period.
However, the stringent product-based regulations are considerably one of the primary factors which is estimated to hamper the market growth in the near future. At the same time, the demand of cystatin C is increasing rapidly with the global prevalence of chronic kidney diseases that is 13.4% globally which is estimated to offer lucrative opportunities to the market growth in the coming years.
Reports and Insights Study identifies some of the key participating players in the Cystatin C Testing Market globally are Abbott, Thermo Fisher, Siemens Healthcare, Eurolyser Diagnostica, Randox Laboratories, DiaSys Diagnostic Systems, Diazyme Laboratories, Tosoh India, BBI Solutions, PerkinElmer, among others.
About Reports and Insights
Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Reports and Insights
For Sales Query: [email protected]
For New Topics & Other Info: [email protected]